Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-166.68M
↓ 33% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-125.33M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-166.68M | +37.6% |
| 2024 | $-266.90M | -91.7% |
| 2023 | $-139.21M | +5.7% |
| 2022 | $-147.57M | +0.8% |
| 2021 | $-148.78M | -110.4% |
| 2020 | $-70.73M | -14.5% |
| 2019 | $-61.76M | -5937.1% |
| 2018 | $-1.02M | - |